209 related articles for article (PubMed ID: 34595766)
1. HPV-associated oropharyngeal cancer de-escalation strategies and trials: Past failures and future promise.
Zakeri K; Dunn L; Lee N
J Surg Oncol; 2021 Nov; 124(6):962-966. PubMed ID: 34595766
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic strategies for systemic therapies of human papillomavirus-related oropharyngeal cancer.
Hung TKW; Ho AL; Pfister DG
J Surg Oncol; 2021 Nov; 124(6):952-961. PubMed ID: 34585389
[TBL] [Abstract][Full Text] [Related]
3. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
[TBL] [Abstract][Full Text] [Related]
4. De-escalation treatment of human papillomavirus-positive oropharyngeal squamous cell carcinoma: an evidence-based review for the locally advanced disease.
Stock GT; Bonadio RRCC; de Castro G
Curr Opin Oncol; 2018 May; 30(3):146-151. PubMed ID: 29474271
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic strategies: Surgery for human papillomavirus-associated oropharyngeal carcinoma.
Mclean T; Fitzgerald C; Boyle JO
J Surg Oncol; 2021 Nov; 124(6):935-944. PubMed ID: 34595753
[TBL] [Abstract][Full Text] [Related]
6. Update on De-intensification and Intensification Studies in HPV.
Mehanna H
Recent Results Cancer Res; 2017; 206():251-256. PubMed ID: 27699545
[TBL] [Abstract][Full Text] [Related]
7. Should We De-escalate the Treatment for HPV-Positive Tumors?
Dietz A; Wichmann G; Wiegand S
Recent Results Cancer Res; 2017; 206():173-181. PubMed ID: 27699538
[TBL] [Abstract][Full Text] [Related]
8. De-escalation in HPV-associated oropharyngeal cancer: lessons learned from the past? A critical viewpoint and proposal for future research.
Petar S; Marko S; Ivica L
Eur Arch Otorhinolaryngol; 2021 Nov; 278(11):4599-4603. PubMed ID: 33599841
[TBL] [Abstract][Full Text] [Related]
9. Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial.
Nichols AC; Lang P; Prisman E; Berthelet E; Tran E; Hamilton S; Wu J; Fung K; de Almeida JR; Bayley A; Goldstein DP; Eskander A; Husain Z; Bahig H; Christopoulous A; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Mendez A; Winquist E; Read N; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Corsten M; Rajaraman M; Johnson-Obaseki S; Eapen L; Odell M; Chandarana S; Banerjee R; Dort J; Matthews TW; Hart R; Kerr P; Dowthwaite S; Gupta M; Zhang H; Wright J; Parker C; Wehrli B; Kwan K; Theurer J; Palma DA
BMC Cancer; 2020 Feb; 20(1):125. PubMed ID: 32059705
[TBL] [Abstract][Full Text] [Related]
10. Optimizing Treatment De-Escalation in Head and Neck Cancer: Current and Future Perspectives.
Rosenberg AJ; Vokes EE
Oncologist; 2021 Jan; 26(1):40-48. PubMed ID: 32864799
[TBL] [Abstract][Full Text] [Related]
11. De-intensification of therapy in human papillomavirus associated oropharyngeal cancer: A systematic review of prospective trials.
Patel RR; Ludmir EB; Augustyn A; Zaorsky NG; Lehrer EJ; Ryali R; Trifiletti DM; Adeberg S; Amini A; Verma V
Oral Oncol; 2020 Apr; 103():104608. PubMed ID: 32163853
[TBL] [Abstract][Full Text] [Related]
12. The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma.
Fung N; Faraji F; Kang H; Fakhry C
Cancer Metastasis Rev; 2017 Sep; 36(3):449-461. PubMed ID: 28812214
[TBL] [Abstract][Full Text] [Related]
13. Novel Strategies to Effectively De-escalate Curative-Intent Therapy for Patients With HPV-Associated Oropharyngeal Cancer: Current and Future Directions.
Price KAR; Nichols AC; Shen CJ; Rammal A; Lang P; Palma DA; Rosenberg AJ; Chera BS; Agrawal N
Am Soc Clin Oncol Educ Book; 2020 Mar; 40():1-13. PubMed ID: 32213088
[TBL] [Abstract][Full Text] [Related]
14. Point/Counterpoint: Do We De-escalate Treatment of HPV-Associated Oropharynx Cancer Now? And How?
Wirth LJ; Burtness B; Nathan CO; Grégoire V; Richmon J
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():364-372. PubMed ID: 31099643
[TBL] [Abstract][Full Text] [Related]
15. Transoral Resection of Human Papillomavirus (HPV)-Positive Squamous Cell Carcinoma of the Oropharynx: Outcomes with and Without Adjuvant Therapy.
Jackson RS; Sinha P; Zenga J; Kallogjeri D; Suko J; Martin E; Moore EJ; Haughey BH
Ann Surg Oncol; 2017 Nov; 24(12):3494-3501. PubMed ID: 28808988
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus: changing paradigms in oropharyngeal cancer.
Adelstein DJ; Rodriguez CP
Curr Oncol Rep; 2010 Mar; 12(2):115-20. PubMed ID: 20425596
[TBL] [Abstract][Full Text] [Related]
17. The interplay of IMRT and transoral surgery in HPV-mediated oropharyngeal cancer: Getting the balance right.
Huang SH; Hahn E; Tsang RK; Chen ZJ; O'Sullivan B
Oral Oncol; 2018 Nov; 86():171-180. PubMed ID: 30409297
[TBL] [Abstract][Full Text] [Related]
18. Patient-reported outcomes in human papillomavirus-related oropharyngeal cancer.
Fitzgerald CWR; Long SM; McLean AT; Cracchiolo JR
J Surg Oncol; 2021 Nov; 124(6):967-976. PubMed ID: 34599762
[TBL] [Abstract][Full Text] [Related]
19. De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies.
Mehanna H; Rischin D; Wong SJ; Gregoire V; Ferris R; Waldron J; Le QT; Forster M; Gillison M; Laskar S; Tahara M; Psyrri A; Vermorken J; Porceddu S
J Clin Oncol; 2020 Aug; 38(22):2552-2557. PubMed ID: 32496903
[TBL] [Abstract][Full Text] [Related]
20. HPV-related oropharyngeal cancers: from pathogenesis to new therapeutic approaches.
Tornesello ML; Perri F; Buonaguro L; Ionna F; Buonaguro FM; Caponigro F
Cancer Lett; 2014 Sep; 351(2):198-205. PubMed ID: 24971935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]